ArticleNeurology(R) neuroimmunology & neuroinflammation2022

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.

Marius Ringelstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.